Haisco Pharmaceutical Group

002653 · SZSE · CNY

¥ 62,18Variação em relação ao fechamento anterior: +0,40%Variação absoluta: +¥ 0,25

Fechamento · 30 de setembro de 2026

Perfil da empresa

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Descrição disponível em inglês.

Dados da empresa

Setor
Saúde
Indústria
Biotechnology
País
China
Sede
No. 17 Sanxiang Avenue, 856000, Shannan
Funcionários
5.597
Listagem
002653 · SZSE
Moeda
CNY